188 related articles for article (PubMed ID: 17568695)
1. Melatonin attenuates the development of antinociceptive tolerance to delta-, but not to mu-opioid receptor agonist in mice.
Dai X; Cui SG; Li SR; Chen Q; Wang R
Behav Brain Res; 2007 Aug; 182(1):21-7. PubMed ID: 17568695
[TBL] [Abstract][Full Text] [Related]
2. Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice.
Li SR; Wang T; Wang R; Dai X; Chen Q; Li RD
Brain Res; 2005 May; 1043(1-2):132-8. PubMed ID: 15862526
[TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
4. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
6. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
Bilsky EJ; Qian X; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
[TBL] [Abstract][Full Text] [Related]
8. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
9. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
10. Mu-opioid receptors are involved in the tolerance to nicotine antinociception.
Galeote L; Kieffer BL; Maldonado R; Berrendero F
J Neurochem; 2006 Apr; 97(2):416-23. PubMed ID: 16539669
[TBL] [Abstract][Full Text] [Related]
11. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
12. Melatonin inhibits the development of tolerance to U-50,488H analgesia via benzodiazepine-GABAAergic mechanisms.
Dhanaraj E; Nemmani KV; Ramarao P
Pharmacol Biochem Behav; 2004 Dec; 79(4):733-7. PubMed ID: 15582681
[TBL] [Abstract][Full Text] [Related]
13. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effect of endomorphin-1.
Li ZH; Shan LD; Jiang XH; Guo SY; Yu GD; Hisamitsu T; Yin QZ
Acta Pharmacol Sin; 2001 Nov; 22(11):976-80. PubMed ID: 11749786
[TBL] [Abstract][Full Text] [Related]
15. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
Rady JJ; Elmer GI; Fujimoto JM
J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
[TBL] [Abstract][Full Text] [Related]
16. JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence.
Codd EE; Carson JR; Colburn RW; Stone DJ; Van Besien CR; Zhang SP; Wade PR; Gallantine EL; Meert TF; Molino L; Pullan S; Razler CM; Dax SL; Flores CM
J Pharmacol Exp Ther; 2009 Apr; 329(1):241-51. PubMed ID: 19151246
[TBL] [Abstract][Full Text] [Related]
17. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Arreola-Espino R; Urquiza-Marín H; Ambriz-Tututi M; Araiza-Saldaña CI; Caram-Salas NL; Rocha-González HI; Mixcoatl-Zecuatl T; Granados-Soto V
Eur J Pharmacol; 2007 Dec; 577(1-3):203-10. PubMed ID: 17920585
[TBL] [Abstract][Full Text] [Related]
18. In vivo regulation of mu-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice.
Duttaroy A; Yoburn BC
Synapse; 2000 Aug; 37(2):118-24. PubMed ID: 10881033
[TBL] [Abstract][Full Text] [Related]
19. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Hiramatsu M; Hoshino T; Kanematsu K
Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]